Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec Pankow, Natalie L. Smith, Xaquin Castro Dopico, Gerald M. McInerney, Jonathan M. Coquet, Gunilla B. Karlsson Hedestam, Ben Murrell
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
SARS-CoV-2
variants of concern
vaccines
original antigenic sin
heterotypic boost
passive immunization
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791

Ejemplares similares